25 studies found for:    PARKINSON DISEASE 12
Show Display Options
Download search resultsDownload the search results for:
PARKINSON DISEASE 12 (25 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed 12-Week, Double-Blind, Placeob-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
2 Completed 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
Condition: Parkinson's Disease
Intervention: Drug: KW-6002 (istradefylline)
3 Recruiting A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Istradefylline 40 mg;   Drug: Istradefylline 20 mg;   Drug: Placebo
4 Completed Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)
Condition: Parkinson's Disease
Interventions: Drug: Safinamide;   Drug: Placebo
5 Completed
Has Results
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
Condition: Parkinson Disease
Interventions: Drug: Pramipexole Immediate Release;   Drug: Pramipexole Extended Release
6 Completed
Has Results
A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexole;   Drug: Placebo
7 Unknown  Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Dietary Supplement: PD vitamin supplementation;   Other: PD exercise intervention;   Other: PD vitamin + exercise
8 Terminated Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Vitamin B12 Supplementation;   Dietary Supplement: Vitamin B12 supplement;   Dietary Supplement: vitamin B12
9 Completed Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease;   Idiopathic Parkinson's Disease
Interventions: Drug: preladenant;   Drug: Placebo to preladenant
10 Completed Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders
Interventions: Drug: AFQ056;   Drug: Placebo
11 Completed Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
Conditions: Parkinson Disease;   Parkinson's Disease
Intervention: Drug: Ropinirole
12 Completed A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
13 Withdrawn Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/levodopa;   Drug: Carbidopa/Levodopa/Entacapone
14 Completed A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Study P04938)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Placebo for Preladenant;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo for Rasagiline 1 mg capsule
15 Completed Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Dyskinesias;   Parkinson's Disease;   Severe Motor Fluctuations
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump
16 Unknown  Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Condition: Parkinson's Disease
Intervention: Drug: Exenatide
17 Completed A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: AZD3241 300 mg BID;   Drug: AZD3241 600 mg BID;   Drug: Placebo
18 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649  (Pitolisant)
19 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649 (pitolisant)
20 Completed A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
Condition: Parkinson's Disease
Interventions: Drug: Preladenant;   Drug: Placebo tablet to match Preladenant

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years